The Pharma Data

JANUARY 18, 2021

The funds will be used to advance its nose-on-chip platform to detect the characteristic smell linked to Parkinson’s disease (PD). Yesse Technologies scientists recently validated the presence of a distinctive smell, arising from an oily skin secretion called sebum, in patients diagnosed with Parkinson’s disease.

Disease 40

Disease Molecular Biology Licensing Licensing 40

The Pharma Data

JANUARY 15, 2021

Marta Laskowski, from the University of Gothenburg in Sweden, and colleagues examined the association between cardiorespiratory fitness and risk for onset of psoriasis and psoriatic arthritis in a cohort of Swedish men in compulsory military service between 1968 and 2005. ” Abstract/Full Text. © 2021 HealthDay.

Disease 52

Disease Research 52

Drug Target Review

MAY 23, 2023

Inflammatory bowel disease (IBD) is an umbrella term that describes complex disorders that cause chronic inflammation in the digestive tract with alternating periods of relapse and remission. A changed composition of the gut microbiota is a characteristic trait of inflammatory bowel disease. More than 6.8

Drugs 75

Drugs Small Molecule Production Disease 75

The Pharma Data

MARCH 5, 2021

Food and Drug Administration (FDA) approved Actemra ® /RoActemra ® (tocilizumab) subcutaneous injection for slowing the rate of decline in pulmonary function in adult patients with systemic sclerosis-associated interstitial lung disease (SSc-ILD), a debilitating condition with limited treatment options. 1-3 SSc affects about 2.5

FDA 52

FDA Disease FDA Approval Therapies 52

The Pharma Data

JANUARY 22, 2021

22, 2021 — For patients with multiple myeloma (MM), those with renal insufficiency (RI) have an increased risk for disease progression or death, according to a systematic review and meta-analysis published online Jan. FRIDAY, Jan. 8 in Leukemia & Lymphoma. Ghulam Rehman Mohyuddin, M.D., for relapsed/refractory MM and 1.07

Clinical Trials 52

Clinical Trials Trials Disease Pharmaceuticals 52

The Pharma Data

OCTOBER 15, 2020

15, 2020 — For women with breast cancer , coronary artery calcium (CAC) detected on radiotherapy (RT)-planning computed tomography (CT) scan is associated with cardiovascular disease (CVD) risk, according to a study presented at the annual European Breast Cancer Conference, held virtually from Oct. THURSDAY, Oct. © 2020 HealthDay.

Disease 52

Disease Research 52

Broad Institute

JANUARY 30, 2024

Bhattacharyya wears many coats today, splitting his time between the Broad and the infectious disease ward at MGH, where a diagnostic method he developed at Broad is now being tested to see if it helps patients quickly receive the best antibiotics for their infections. A combined MD/PhD program offered both opportunities.

Hospitals 137

Hospitals Virus Medical Schools Science 137

Drug Target Review

APRIL 9, 2024

How has nucleolar stress (NS) been linked to age-related diseases, and what approach did researchers use to investigate its toxicity? The nucleolus (and nucleolar stress) had been previously linked to aging and age-related diseases such as cancer or degeneration.

RNA 64

RNA Cell Biology Clinical Development Disease 64

The Pharma Data

JANUARY 15, 2021

Centers for Disease Control and Prevention Morbidity and Mortality Weekly Report. Screening receipt remained below targets for breast and cervical cancer, with little change from 2005 to 2018. FRIDAY, Jan. 14 issue of the U.S. Sabatino, M.D., percent of adults aged 50 to 75 years up to date with testing compared with target of 70.5

Disease 52

Disease Research 52

DrugBank

JUNE 27, 2023

Out of the millions of genetic variants present in human populations, GWAS are designed to uncover those associated with specific traits or diseases. 9 Polygenic diseases are much more common, and thousands of genetic variants with very small effects could impact their phenotype.

Disease 98

Disease Treatment Drugs Clinical Trials 98

The Pharma Data

JUNE 25, 2021

protofibril antibody for the treatment of Alzheimer’s disease (AD). in individuals newly treated with lecanemab and was presented at the 2021 Alzheimer’s Disease and Parkinson’s Disease Conference. As such, lecanemab may have the potential to have an effect on disease pathology and to slow down the progression of the disease.

Disease 40

Disease Treatment Therapies FDA 40

The Pharma Data

NOVEMBER 5, 2020

The resumed session will discuss a 10-year-plan for addressing neglected tropical diseases, as well as efforts to address meningitis, epilepsy and other neurological disorders, maternal infant and young child nutrition, digital health, and the WHO Global Code of Practice on the International Recruitment of Health Personnel, adopted in 2010.

International 52

International Compliance Virus Vaccine 52

The Pharma Data

MAY 26, 2023

Tobacco farming causes diseases to the farmers themselves and more than 1 million child laborers are estimated to be working on tobacco farms, missing their opportunity for an education. Since 2005, there has been a nearly 20% increase in tobacco farming land across Africa. Tobacco growing is a global problem.

Government 52

Government Disease 52

Agency IQ

APRIL 19, 2024

FDA advisors endorse minimal residual disease (MRD) as accelerated approval endpoint for multiple myeloma Last week, FDA’s Oncologic Drugs Advisory Committee (ODAC) voted unanimously in favor of using minimal residual disease (MRD) as an accelerated approval endpoint for multiple myeloma.

FDA 40

FDA Disease Trials Clinical Trials 40

The Pharma Data

JUNE 2, 2022

Dr. Yang joined Gilead in 1993 and became Senior Vice President of Pharmaceutical Development and Manufacturing in 2005. In a career with Gilead that has spanned almost three decades, Taiyin has worked on medicines that have helped millions of people living with HIV, liver disease and cancer. About Gilead Sciences.

Science 52

Science Pharmaceuticals Engineering Production 52

The Pharma Data

AUGUST 3, 2021

The Gilead Foundation, established in 2005, builds on the company’s longstanding commitment to supporting underserved communities around the world. (Nasdaq: GILD) today announced a more than $200 million endowment to the Gilead Foundation to further the company’s vision of creating a healthier world for all people.

Science 52

Science International Disease 52

The Open Targets Blog

FEBRUARY 22, 2023

New evidence for target-disease associations Gene burden analysis of metabolic biomarkers We have integrated data from Riveros-McKay et al. New evidence for target-disease associations Gene burden analysis of metabolic biomarkers We have integrated data from Riveros-McKay et al.

Disease 52

Disease Production Regulations Drugs 52

The Pharma Data

JANUARY 17, 2021

The treatment could be administered in primary care centers to people who test positive for COVID-19, avoiding hospitalization due to the progression of the disease and complementing the vaccine in the early phase after vaccination. BARCELONA, Spain , Jan. 18, 2021 /PRNewswire/ — Grifols (MCE: GRF, MCE: GRF.P,

Clinical Trials 52

Clinical Trials Treatment Trials Virus 52

Drug Target Review

FEBRUARY 7, 2024

For example, innate immune peptides being imitated by SARS-CoV-2 fragments have a special ability to organise double stranded RNA into structures that strongly amplify activation of the human innate immune system in autoimmune diseases. He currently serves on the Editorial Board of Physical Review E.

RNA 69

RNA Virus Immune Response Engineering 69

Drug Target Review

FEBRUARY 28, 2024

Human γδ TCR repertoires in health and disease. Chem Immunol Allergy 86:151-183 (2005). Increased frequency of TCR gamma delta + T cells in disease-free survivors following T cell-depleted, partially mismatched, related donor bone marrow transplantation for leukemia. References Fichtner A, Ravens S, Prinz I.

Therapies 105

Therapies Engineering Molecular Biology Science 105

Alta Sciences

APRIL 17, 2024

Gene Therapy Gene therapy is currently considered for diseases, often rare, that have no other cures. We have conducted over 130 in-life studies in the last five years (over 95% conducted in NHPs), including IND-enabling studies for rare diseases and CRISPR gene editing therapeutics in NHPs.

Drug Development 52

Drug Development Treatment FDA Approval Drugs 52

The Pharma Data

MARCH 11, 2021

Actemra/RoActemra can be used alone or with methotrexate (MTX) in adult RA patients who are intolerant to, or have failed to respond to, other disease-modifying anti-rheumatic drugs (DMARDs). for slowing the rate of decline in pulmonary function in adult patients with systemic sclerosis-associated interstitial lung disease (SSc-ILD).

Trials 52

Trials Hospitals Treatment Science 52

The Pharma Data

MARCH 17, 2022

AstraZeneca today launched a global R&D Postdoctoral Challenge to help accelerate ideas to transform the treatment of some of the world’s most complex diseases. Rapid progress in disease understanding, as well as scientific and technological advances are genuinely changing our expectations of what is possible.

Science 40

Science Clinical Trials Disease Research 40

Drug Target Review

SEPTEMBER 20, 2023

From 2005 to 2008 he carried out a DPhil (PhD) at Oxford on nanomaterials for quantum computation, followed by postdoctoral work on the prediction of crystal structures at University College London. Training AI/ML tools to predict results of otherwise complex and time-consuming calculations is gaining traction in pharmaceutical R&D.

Drugs 105

Drugs Metabolic Stability Computational Chemistry Pharmaceuticals 105

The Pharma Data

NOVEMBER 25, 2020

Vifor Pharma Group strives to help patients around the world with severe and chronic diseases lead better, healthier lives. Even without anemia, iron deficiency can be debilitating, exacerbate an underlying chronic disease and lead to increased morbidity and mortality 4. Worldwide prevalence of anaemia 1993-2005. Am J Clin Nutr.

International 52

International Pharmaceuticals Disease Pharmaceutical Companies 52

Codon

JUNE 11, 2024

Biologists use nanopores for everything from diagnosing diseases and monitoring changes within rainforest ecosystems to discovering proteins from microbes frozen in Icelandic glaciers. Such a device seems implausible. But these little machines, small enough to fit inside a pocket, have become commonplace.

DNA 85

DNA Engineering RNA Small Molecule 85

The Pharma Data

AUGUST 24, 2020

The disease is now only found in Afghanistan and Pakistan. Without a cure a vaccine developed in 1952 by Dr Jonas Salk gave hope that children could be protected from the disease. The country remained free from polio for four years until 2005 when a number of cases were thought to have been brought in from outside the country.

Vaccine 52

Vaccine Virus Disease Laboratories 52

The Pharma Data

DECEMBER 18, 2020

Back in 2005, a small study found that the devices tended to overestimate oxygen levels in dark-skinned patients. Centers for Disease Control and Prevention has more on monitoring COVID-19 at home. . . That compared with 6% among white patents. The notion of a racial bias in pulse oximetry is not new. More Information.

Hospitals 52

Hospitals Medical Schools International Doctors 52

Codon

APRIL 9, 2024

“Cumulatively the deadliest of the human infectious diseases,” malaria has been documented throughout recorded history. In this light, scouring old Chinese remedies for new treatments for a disease specifically troublesome during war was entirely intuitive for Chinese biomedical scientists like Tu Youyou in the mid-20th century.

Drugs 137

Drugs Science Research Doctors 137

The Pharma Data

JULY 29, 2021

Food and Drug Administration (FDA) in June 2021 — following 18 months of treatment in the open-label extension (OLE) of the Phase 2b proof-of-concept study in subjects with early Alzheimer’s disease (AD) (Mild Cognitive Impairment [MCI] due to AD and mild AD) at the Alzheimer’s Association International Conference (AAIC) held in Denver, Colo.,

Clinical Trials 52

Clinical Trials Treatment Disease Clinical Development 52

Alta Sciences

OCTOBER 9, 2024

Since 2005, the PharmaVoice 100 has become one of the publication’s most anticipated features. Each winner represents the transformative impact of the pharmaceutical industry in their own unique way. Each winner represents progress toward a healthier future for everyone that is bolstered by science and technological advancements.

Clinical Pharmacology 40

Clinical Pharmacology Drug Development Science Clinical Trials 40

The Pharma Data

JANUARY 6, 2021

In two exploratory cohorts, up to 100 patients with moderate Chronic Kidney Disease (CKD) and up to 100 patients with COVID-19 will be enrolled. AM-Pharma’s purpose is to save and improve the lives of patients confronted with kidney disease, sepsis and organ injury. 7, 2021 10:00 UTC. About AM-Pharma. and Chawla L.S.

Trials 52

Trials Hospitals Treatment International 52

PLOS: DNA Science

APRIL 13, 2023

The first SNP map was published in 2001 and the first GWAS in 2005. The new study also reveals genetic patterns that predict addiction to two or more substances, as well as elevated risk of mental and physical illnesses, including psychiatric disorders, suicidal behavior, respiratory disease, heart disease, and chronic pain conditions.

DNA 52

DNA Drugs Treatment Science 52

Vial

MAY 8, 2024

A Brief Introduction Medrio was founded in 2005 with the mission to revolutionize clinical research with the creation of the first cloud-based EDC system, designed to simplify data collection without requiring advanced programming skills.

Clinical Trials 52

Clinical Trials Trials Clinical Research Laboratories 52

The Pharma Data

DECEMBER 14, 2020

Even though early-stage non-small-cell lung cancer (NSCLC) generally demonstrates a good prognosis after surgery, a significant proportion of early-stage NSCLC patients suffer from fast relapse, which is generally attributable to metastatic disease undetected at complete resection. 2 Woodard et al., 3 Shi JF et al., Lung Cancer.

Licensing 52

Licensing Licensing Pharmaceutical Companies Treatment 52

PLOS: DNA Science

JUNE 22, 2023

Cancer cells make too much survivin, with levels increasing as the disease spreads and becomes more aggressive. It delayed disease progression and more than doubled survival time, adding 17 months. She chronicled her journey in Glamour and in My So-Called Normal Life, a book published in 2005. Here’s an article from 2002.

Drugs 52

Drugs Small Molecule DNA Bioethics 52

Common Sense for Drug Policy Blog

JANUARY 1, 2024

million in 2014, 13 allowing for greater coverage of injection events and more opportunities for disease prevention. "By From 2005 to 2014, the SEP returned to the less restrictive 1:1 policy, after which they shifted to a need-based distribution model whereby PWID could access as many syringes as needed. in 1999 to 1.82

Treatment 40

Treatment Government Regulations Disease 40